Some good news to start the day: Complete Response in First Patient Ever Treated with 2 Doses of Cu-67 SAR-bisPSMA at 8GBq...6 months

[Maxone73]

I have already written about this, but then he approached the 6 months mark, so...

"The patient remains with undetectable levels of Prostate Specific Antigen (PSA) for almost 6 months, following the administration of the second dose of 67Cu-SAR-bisPSMA. PSA is a marker used to assess clinical response to treatment and an indicator of the recurrence of prostate cancer."

"Especially as we have now entered our first multi-dose cohort of the SECuRE trial, cohort 4, at a dose level of 12GBq, where we have already seen incredible benefits in patients that have failed so many lines of therapy. We hope to replicate this remarkable result in many patients and confirm the favourable safety profile of this agent."

must keep an eye on this, I am wondering about the results for the other patients dosed...

urotoday.com/recent-abstrac...

[Ramp7]

Looks promising, I shall keep an eye on this one. Thanks

[God_Loves_Me]

Are there any clincal trials in USA?

[KocoPr in reply to God_Loves_Me]

I think in my other group cancer patient lab we have one warrior going into a trial run by xcancer out of omaha.

xcancer.com

[Shams_Vjean in reply to God_Loves_Me]

Omaha: - as per KocoPr above

NYC: - Scott Tagawa jcto.weill.cornell.edu/open...

Mayo-Rochester, MN: - Oliver Sator

St. Louis, MO: - Vikas Prasad

ClinicalTrials.gov: NCT04868604

I was considering this one, but opted for Pluvicto instead. Glad to hear the positive results are continuing.

[Pmann]

Really promising, it is always good to show that there are more ways coming to fight this dreadful disease.

[leo2634]

Giving us real hope, My friends . Never give up Never surrender Leo

[marlins1]

Where is the publication? What is the effective process? Just says it works.

[Maxone73 in reply to marlins1]

Type Cu-67 SAR-bisPSMA in google, but I think the first statistical data are due before the end of the year, they are at cohort 4

[Shams_Vjean in reply to marlins1]

Total enrollment of about 40 in the US for the current phase I/IIa trial is just getting underway at some clinics here. An Initial phase I trial was with 6 patients in Australia.

Developed by Clarity Pharmaceuticals, a Theranostics company out of Australia. The company’s website gives a brief overview of the mechanism.

youtu.be/QJz7dyxdEJo?si=CAQ...(Not working as expected?)